Kush Parmar sold $1.8M of Entrada Therapeutics (TRDA)

Executed Nov 14 2025, disclosed Nov 18 2025, 4 days later.

Value, as filed

$1.8M

200,000 sh × $8.80

Executed

Nov 14 2025

the trade date, as filed

Disclosed

Nov 18 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Kush Parmar Director profile →

Kush Parmar (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Entrada Therapeutics, Inc. (TRDA). The largest single filing was $1.8M of TRDA (200,000 sh × $8.80, as filed), executed Nov 14 2025.

The name

TRDA

Entrada Therapeutics, Inc. TRDA · Healthcare · 31 filings in 24 months ticker →

Healthcare · Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kush Parmar in TRDA

TRDASALE Entrada Therapeutics, Inc. $1.0M
144,761 sh across 2 lots
Exec Aug 7
Filed Aug 10 · 7:54 PM ET TRDASALE Entrada Therapeutics, Inc. $795K
114,756 sh × $6.93
Exec Jul 30
Filed Aug 3 · 5:26 PM ET TRDASALE Entrada Therapeutics, Inc. $150K
20,065 sh × $7.50
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET TRDASALE Entrada Therapeutics, Inc. $777K
112,156 sh across 4 lots
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET